Skip to content
value.today

MaxCyte, Inc. vs Neuronetics, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • MaxCyte, Inc. and Neuronetics, Inc. are worth about the same: $156 M and $162 M (market caps of Oct 27, 2026 for MaxCyte, Inc. and Oct 23, 2026 for Neuronetics, Inc.).
  • Neuronetics, Inc. had more revenue: $149 M against $33 M for MaxCyte, Inc., both in the year to December 2025.
  • Both made a net loss: $45 M for MaxCyte, Inc. and $39 M for Neuronetics, Inc.
  • Neuronetics, Inc. keeps more of each dollar of sales: a net margin of -26.1% against -135.1% for MaxCyte, Inc.
  • Neuronetics, Inc.'s revenue grew faster in its latest fiscal year: +99.2% against -14.5% for MaxCyte, Inc.
  • Both are in the distress zone of the Altman Z-score.

Market value, the same start = 100

From Jan 2022: how each one's value moved, whatever its size.

0631271902542023202420252026MaxCyte, Inc. 17Neuronetics, Inc. 163

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025MaxCyte, Inc. $0BNeuronetics, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureMaxCyte, Inc.
MXCT · #17,164 in the world
Neuronetics, Inc.
STIM · #17,042 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryDiagnostics and ResearchDiagnostics and Research
Founded19982003
Size
Market cap$156 M$162 M
Revenue$33 M$149 M
Net income$-45 M$-39 M▲ best
Employees91—
Valuation
Price to sales4.5×1.0×
Price to book0.9×7.2×
Free cash flow yield-23.2%-13.1%▲ best
Profitability
Gross margin81.1%▲ best48.5%
Operating margin-157.1%-21.1%▲ best
Net margin-135.1%-26.1%▲ best
Return on equity-23.6%▲ best-155.7%
Growth
Revenue growth-14.5%99.2%▲ best
Revenue growth, 3 years a year-9.3%31.8%▲ best
Financial strength
Debt to equity—2.9×
Interest cover—-4.1×
Cash
Free cash flow margin-109.5%-14.2%▲ best
Strength scores
Piotroski F-score—4 of 9
Altman Z-score zonedistressdistress
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, MaxCyte, Inc. or Neuronetics, Inc.?

MaxCyte, Inc. and Neuronetics, Inc. are worth about the same: $156 M and $162 M (market caps of Oct 27, 2026 for MaxCyte, Inc. and Oct 23, 2026 for Neuronetics, Inc.).

Which makes more money, MaxCyte, Inc. or Neuronetics, Inc.?

Neuronetics, Inc. had more revenue: $149 M against $33 M for MaxCyte, Inc., both in the year to December 2025. Both made a net loss: $45 M for MaxCyte, Inc. and $39 M for Neuronetics, Inc.

Which is more profitable, MaxCyte, Inc. or Neuronetics, Inc.?

Neuronetics, Inc. keeps more of each dollar of sales: a net margin of -26.1% against -135.1% for MaxCyte, Inc.

Which is growing faster, MaxCyte, Inc. or Neuronetics, Inc.?

Neuronetics, Inc.'s revenue grew faster in its latest fiscal year: +99.2% against -14.5% for MaxCyte, Inc.

Which is financially stronger, MaxCyte, Inc. or Neuronetics, Inc.?

Both are in the distress zone of the Altman Z-score.

Sources#

Every figure on this page comes from these, with the date shown next to it.